Literature DB >> 20947777

Depression predicts elevated endothelin-1 in patients with coronary artery disease.

Matthew M Burg1, Elisabeth J Martens, Dorothea Collins, Robert Soufer.   

Abstract

OBJECTIVE: To examine the relationship of depression severity to circulating endothelin-1 (ET-1), which has previously been linked to plaque rupture and postacute coronary syndrome (ACS) survival. Depression carries an independent two- to four-fold increased risk of early morbidity and mortality after ACS. The pathway(s) linking depression to event-free survival remains to be determined.
METHODS: Patients with documented history of coronary artery disease (n = 101) provided a resting morning blood sample that was assayed for ET-1, and they completed the Beck Depression Inventory (BDI). ET-1 was treated as a log-transformed continuous variable (logET-1), and as a dichotomous variable using a post-ACS risk threshold previously reported (≥1.16 fmol/mL).
RESULTS: BDI score was related to logET-1 in both unadjusted and adjusted models. In addition, unadjusted and adjusted logistic regression models with dichotomous ET-1 revealed that, for each point increase in BDI score, there was approximately a 14% increased likelihood of being at or above ET-1 risk threshold. Secondary logistic regression models demonstrated a >3.5-fold likelihood of being at or above this risk threshold in association with a BDI score of ≥10.
CONCLUSIONS: Depression symptom severity predicts ET-1 elevation that has previously been linked to post-ACS survival, with the greatest risk of elevation among those patients with worse depression symptoms. This link may identify a vulnerability to triggered ACS and poorer survival associated with depression. Future research should establish whether the observed relationship of depressive symptoms to ET-1 level mediates the link between depression and survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947777      PMCID: PMC3016462          DOI: 10.1097/PSY.0b013e3181fdfb25

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  49 in total

1.  Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction.

Authors:  N Honzíková; B Semrád; B Fiser; R Lábrová
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

2.  Myocardial blood-flow response during mental stress in patients with coronary artery disease.

Authors:  J A Arrighi; M Burg; I S Cohen; A H Kao; S Pfau; T Caulin-Glaser; B L Zaret; R Soufer
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

3.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Authors:  L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

4.  Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery disease.

Authors:  Antonio B Fernandez; Robert Soufer; Dorothea Collins; Aaron Soufer; Hooman Ranjbaran; Matthew M Burg
Journal:  Psychosom Med       Date:  2010-04-05       Impact factor: 4.312

5.  Mental stress induces transient endothelial dysfunction in humans.

Authors:  L Ghiadoni; A E Donald; M Cropley; M J Mullen; G Oakley; M Taylor; G O'Connor; J Betteridge; N Klein; A Steptoe; J E Deanfield
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

6.  Endothelin-1 and prevalent coronary heart disease in older men and women (the Rancho Bernardo Study).

Authors:  Alka M Kanaya; Elizabeth Barrett-Connor; Christina L Wassel Fyr
Journal:  Am J Cardiol       Date:  2006-12-27       Impact factor: 2.778

Review 7.  Current perspectives of the roles of the central norepinephrine system in anxiety and depression.

Authors:  Andrew W Goddard; Susan G Ball; James Martinez; Michael J Robinson; Charles R Yang; James M Russell; Anantha Shekhar
Journal:  Depress Anxiety       Date:  2010-04       Impact factor: 6.505

8.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.

Authors:  Judith H Lichtman; J Thomas Bigger; James A Blumenthal; Nancy Frasure-Smith; Peter G Kaufmann; François Lespérance; Daniel B Mark; David S Sheps; C Barr Taylor; Erika Sivarajan Froelicher
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

9.  Screening for depression in adults: U.S. preventive services task force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-12-01       Impact factor: 25.391

10.  Circadian rhythm disorder of thrombosis and thrombolysis-related gene expression in apolipoprotein E knock-out mice.

Authors:  Xueqing Zhang; Fengdi Zhao; Chen Xu; Chao Lu; Huiming Jin; Sifeng Chen; Ruizhe Qian
Journal:  Int J Mol Med       Date:  2008-08       Impact factor: 4.101

View more
  15 in total

1.  Two-year prognosis after acute coronary syndrome in younger patients: Association with feeling depressed in the prior year, and BDI-II score and Endothelin-1.

Authors:  Luba Yammine; Lorraine Frazier; Nikhil S Padhye; Jennifer E Sanner; Matthew M Burg
Journal:  J Psychosom Res       Date:  2017-05-23       Impact factor: 3.006

2.  The interface of emotion and biology in myocardial ischemia: Can we progress using the traditional paradigm?

Authors:  Robert Soufer; Matthew M Burg
Journal:  J Nucl Cardiol       Date:  2017-02-02       Impact factor: 5.952

Review 3.  Heartache and heartbreak--the link between depression and cardiovascular disease.

Authors:  Charles B Nemeroff; Pascal J Goldschmidt-Clermont
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

4.  Severe depressive symptoms are associated with elevated endothelin-1 in younger patients with acute coronary syndrome.

Authors:  Luba Yammine; Lorraine Frazier; Nikhil S Padhye; Matthew M Burg; Janet C Meininger
Journal:  J Psychosom Res       Date:  2014-08-02       Impact factor: 3.006

5.  Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome.

Authors:  Christopher M Celano; Eleanor E Beale; Scott R Beach; Arianna M Belcher; Laura Suarez; Shweta R Motiwala; Parul U Gandhi; Hanna Gaggin; James L Januzzi; Brian C Healy; Jeff C Huffman
Journal:  Psychosom Med       Date:  2017-04       Impact factor: 4.312

Review 6.  The 'perfect storm' and acute coronary syndrome onset: do psychosocial factors play a role?

Authors:  Matthew M Burg; Donald Edmondson; Daichi Shimbo; Jonathan Shaffer; Ian M Kronish; William Whang; Carmela Alcántara; Joseph E Schwartz; Paul Muntner; Karina W Davidson
Journal:  Prog Cardiovasc Dis       Date:  2013-04-06       Impact factor: 8.194

7.  Lifetime history of depression, type 2 diabetes, and endothelial reactivity to acute stress in postmenopausal women.

Authors:  Julie A Wagner; Howard Tennen; Patrick H Finan; William B White; Matthew M Burg; Nimrta Ghuman
Journal:  Int J Behav Med       Date:  2012-12

Review 8.  Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.

Authors:  Mohammad Amin Khodadadegan; Shakiba Azami; Paul C Guest; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  From Heartbreak to Heart Disease: A Narrative Review on Depression as an Adjunct to Cardiovascular Disease.

Authors:  Jahanzeb Malik; Hamid Sharif Khan; Faizan Younus; Muhammad Shoaib
Journal:  Pulse (Basel)       Date:  2021-05-31

10.  Recurrent versus new-onset depressive symptoms: Relationships with biomarkers of cardiovascular health following acute coronary syndrome.

Authors:  Elizabeth N Madva; Christopher M Celano; Diana M Smith; James L Januzzi; Jeff C Huffman
Journal:  J Psychosom Res       Date:  2020-11-11       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.